Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Einar Gude

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
ESC Heart Failure|February 15, 2020
Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipientsNiklas Bergh, Einar Gude, Sven-Erik Bartfay, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 21, 2023
A man in his seventies with fatigue and renal failureMargrethe Flesvig Holt, August Flø, Vilde Bjørnø, et al.
Plos One|May 23, 2012
Increased levels of inflammatory cytokines and endothelin-1 in alveolar macrophages from patients with chronic heart failureLiv I Bjoner Sikkeland, Christen P Dahl, Thor Ueland, et al.
Clinical Transplantation|May 24, 2020
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trialKaspar Broch, Einar Gude, Kristjan Karason, et al.
International Journal of Cardiology. Heart & Vasculature|October 27, 2025
Increased dipeptidyl peptidase 4 in patients with concomitant transthyretin cardiac amyloidosis and severe aortic stenosisMargrethe Flesvig Holt, Annika E Michelsen, August Flø, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 22, 2024
Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trialEntela Bollano, Arne K Andreassen, Hans Eiskjaer, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 27, 2025
Chronic thromboembolic pulmonary hypertensionJohn-Peder Escobar Kvitting, Håvard Ravnestad, Rune Andersen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2021
Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic SclerosisHenriette Didriksen, Øyvind Molberg, Håvard Fretheim, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 28, 2018
Mean Right Atrial Pressure for Estimation of Left Ventricular Filling Pressure in Patients with Normal Left Ventricular Ejection Fraction: Invasive and Noninvasive ValidationSherif F Nagueh, Otto A Smiseth, Hisham Dokainish, et al.
Circulation. Heart Failure|October 26, 2018
Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant RecipientsSatish Arora, Arne K Andreassen, Kristjan Karason, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
ESC Heart Failure|February 15, 2020
Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipientsNiklas Bergh, Einar Gude, Sven-Erik Bartfay, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 21, 2023
A man in his seventies with fatigue and renal failureMargrethe Flesvig Holt, August Flø, Vilde Bjørnø, et al.
Plos One|May 23, 2012
Increased levels of inflammatory cytokines and endothelin-1 in alveolar macrophages from patients with chronic heart failureLiv I Bjoner Sikkeland, Christen P Dahl, Thor Ueland, et al.
Clinical Transplantation|May 24, 2020
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trialKaspar Broch, Einar Gude, Kristjan Karason, et al.
International Journal of Cardiology. Heart & Vasculature|October 27, 2025
Increased dipeptidyl peptidase 4 in patients with concomitant transthyretin cardiac amyloidosis and severe aortic stenosisMargrethe Flesvig Holt, Annika E Michelsen, August Flø, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 22, 2024
Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trialEntela Bollano, Arne K Andreassen, Hans Eiskjaer, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 27, 2025
Chronic thromboembolic pulmonary hypertensionJohn-Peder Escobar Kvitting, Håvard Ravnestad, Rune Andersen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2021
Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic SclerosisHenriette Didriksen, Øyvind Molberg, Håvard Fretheim, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 28, 2018
Mean Right Atrial Pressure for Estimation of Left Ventricular Filling Pressure in Patients with Normal Left Ventricular Ejection Fraction: Invasive and Noninvasive ValidationSherif F Nagueh, Otto A Smiseth, Hisham Dokainish, et al.
Circulation. Heart Failure|October 26, 2018
Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant RecipientsSatish Arora, Arne K Andreassen, Kristjan Karason, et al.
Pageof 10